The stock is in a powerful, sustained uptrend, evidenced by a staggering 369.33% gain over the past year, but is currently experiencing volatile consolidation near its recent highs. With a current price of $403.2, it is trading at approximately 95.5% of its 52-week high of $422.11, indicating it is near the peak of its recent range, which reflects strong momentum but also suggests potential overextension and vulnerability to a pullback. The 1-month and 3-month price changes of +10.96% and +40.77%, respectively, show that short-term momentum remains robust and is accelerating relative to the broader market, as indicated by a relative strength of +11.04% over one month, though the price action has been highly volatile with a recent maximum drawdown of -26.73%. Key technical support is anchored at the 52-week low of $83.0, but more relevant near-term support lies in the $300-$320 zone where the stock consolidated in March, while immediate resistance is at the 52-week high of $422.11; a decisive breakout above this level could signal a continuation of the powerful uptrend, while a breakdown below $300 might indicate a deeper correction. The stock's beta of 1.79 confirms it is approximately 79% more volatile than the broader market, which is critical for risk management as it implies amplified moves both up and down.

Revenue growth has been explosive, with Q4 2025 revenue of $1.08 billion representing a 43.9% year-over-year increase, and the sequential trend from Q1 to Q4 2025 shows revenue accelerating from $686 million to over $1 billion, indicating strong demand momentum, particularly in its core semiconductor test business. The company is highly profitable, with Q4 2025 net income of $257.2 million and a gross margin of 57.49%, and while the quarterly net margin has fluctuated between 12.0% and 23.7% in 2025, the most recent quarter's net margin of 23.7% and operating margin of 28.6% demonstrate significant operating leverage and margin expansion as revenue scales. The balance sheet is exceptionally strong with a low debt-to-equity ratio of 0.124, a healthy current ratio of 1.76, and robust cash generation evidenced by trailing twelve-month free cash flow of $450.4 million and an ROE of 19.82%, indicating the company can fund its growth and shareholder returns internally without reliance on excessive debt.